Erratum: Author correction to ‘Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents’ [Acta Pharmaceutica Sinica B 9 (2019) 335–350, (S2211383518306063), (10.1016/j.apsb.2019.01.003)]

doi:10.1016/j.apsb.2022.05.030

科研成果详情

名称	Erratum: Author correction to ‘Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents’ [Acta Pharmaceutica Sinica B 9 (2019) 335–350, (S2211383518306063), (10.1016/j.apsb.2019.01.003)]
作者	Wang, Jiabing 1,2; Huang, Lili 1,3; Chen, Chanchan1; Li, Ge1; Xie, Jingwen 1; Shen, Mengya1; Chen, Qian1; Li, Wulan1,4; He, Wenfei1; Qiu, Peihong 1; Wu, Jianzhang1
发表期刊	Acta Pharmaceutica Sinica B;
语种	英语
原始文献类型	Erratum
摘要	The authors regret that there was a picture error in Fig. 5D and Fig. 5E, owing to the authors’ mistakes of copying and pasting in the process of assembling figures and making a diagram. In Fig. 5D, the image of the edaravone 6 h group (ED-6h group) was repeated with the model group (NS group), and thus the image of the ED-6h group needs to be corrected. In Fig. 5E, the data of the edaravone 3h group (ED-3h group) was repeated with the 33 6h group (33-6h group), and thus the data of the ED-3h group needs to be corrected. The raw data of correct images of ED-6h group in Fig. 5D and Fig. 5E are provided, as well as the raw data of NS group. The authors revise Fig. 5D and Fig. 5E as below. The revisions do not affect any results and conclusions of the current work. The authors apologize for any inconvenience caused to the journal and readers. The raw data of correct image of ED-6h group and NS group in Fig. 5D are: [Table presented] The raw data of correct histogram in Fig. 5E are: [Table presented] After the correction of 5D, the Fig. 5 is:[Formula presented]
出版者	INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
ISSN	2211-3835
EISSN	2211-3843
卷号	12
期号	8
页码	3451-3452
DOI	10.1016/j.apsb.2022.05.030
页数	2
WOS类目	Pharmacology & Pharmacy
WOS研究方向	Pharmacology & Pharmacy
WOS记录号	WOS:000842459600003
收录类别	SCOPUS ; SCIE
发布日期	2022-08-01
URL	查看原文
PubMed ID	3596728
通讯作者地址	[Qiu, Peihong;Wu, Jianzhang]Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Peoples R China.
Scopus学科分类	Pharmacology, Toxicology and Pharmaceutics (all)
SCOPUSEID	SCOPUS_ID:85136260065
引用统计
文献类型	其他
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/184782
专题	药学院（分析测试中心）第一临床医学院（信息与工程学院）、附属第一医院_计算机与信息管理系
通讯作者	Qiu, Peihong; Wu, Jianzhang
作者单位	1.Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Peoples R China; 2.Taizhou Univ, Sch Med, Municipal Hosp, Taizhou 318000, Peoples R China; 3.Li Huili Hosp, Ningbo Med Ctr, Ningbo 315041, Peoples R China; 4.Wenzhou Med Univ, Coll Informat Sci & Comp Engn, Wenzhou 325035, Peoples R China
第一作者单位	药学院（分析测试中心）
通讯作者单位	药学院（分析测试中心）
推荐引用方式 GB/T 7714	Wang, Jiabing,Huang, Lili,Chen, Chanchan,et al. Erratum: Author correction to ‘Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents’ [Acta Pharmaceutica Sinica B 9 (2019) 335–350, (S2211383518306063), (10.1016/j.apsb.2019.01.003)]. 2022.